Skip Navigation
Skip to contents

Scientific Program

Filter
SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[JS03] Joint Session 03 (ASH-KSH)

Emerging Therapeutic Landscape for Unfit AML

Galaxy Theater
  • March 27 (Fri), 09:00-10:15
  • Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea)
    Pamela S. Becker (City of Hope, USA)
  • 09:00-09:15 Multi-Omic Precision Medicine including Functional Drug Screening to Optimize Treatment for Acute Myeloid Leukemia Pamela S. Becker (City of Hope, USA) 09:15-09:30 Novel Immunotherapeutic Strategies: Preclinical Insights Ji Eun Jang (Yonsei University College of Medicine, Korea) 09:30-09:45 Developing Next-Generation Cell Therapy Approaches for AML Paulina Velasquez (St. Jude Children’s Research Hospital, USA) 09:45-10:00 Emerging Ex-vivo Drug Sensitivity Platforms Daehun Kwag (College of Medicine, The Catholic University of Korea, Korea) 10:00-10:15 Discussion

[SS08] Scientific Session 08

Microbiome-Driven Precision Medicine in Hematology

Discovery Hall
  • March 27 (Fri), 09:00-10:15
  • Myung Geun Shin (Chonnam National University Medical School, Korea)
    Hyery Kim (University of Ulsan College of Medicine, Korea)
  • 09:00-09:25 Microbiome-Driven Precision Medicine in CAR-T Cell Therapy in Hematology Christoph K. Stein-Thoeringer (University Clinic Tübingen, Germany) 09:25-09:50 Gut Microbiome as a Predictive Biomarker and Emerging Intervention Target in DLBCL Woorim Kang (Kangwon National University, Korea) 09:50-10:15 Microbiome in Allogeneic Hematopoietic Cell Transplantation & Immunotherapy Jonathan U. Peled (Memorial Sloan Kettering Cancer Center, USA)

[SS09] Scientific Session 09

Future of Immunotherapy in DLBCL

Universe Arena
  • March 27 (Fri), 09:00-10:15
  • Jae-Yong Kwak (Jeonbuk National University Medical School, Korea)
    Sung Yong Oh (Dong-A University College of Medicine, Korea)
  • 09:00-09:25 A Personalized Approach to Immune Therapies for Cancer: One Drug, One Patient Larry W. Kwak (City of Hope, USA) 09:25-09:50 Paradigm Shift in the Treatment of Diffuse Large B-cell Lymphoma: The Era of Bispecific Antibodies Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) 09:50-10:15 Toward a Paradigm Shift in Personalized Therapies for DLBCL Using Liquid Biopsies Ash A. Alizadeh (Stanford University, USA)

[ES04] Education Session 04

Understanding Anemia

Supernova Stage
  • March 27 (Fri), 09:00-10:15
  • Eun Sun Yoo (Ewha Womans University College of Medicine, Korea)
    Jun Eun Park (Korea University College of Medicine, Korea)
  • 09:00-09:25 Iron Deficiency & Iron Metabolism Jeong-Ok Lee (Seoul National University College of Medicine, Korea) 09:25-09:50 Hereditary Hemolytic Anemia Heewon Chueh (Inje University College of Medicine, Korea) 09:50-10:15 Cold Agglutinin Disease Dae-Ho Choi (Sungkyunkwan University School of Medicine, Korea)

[PL02] Plenary Lecture 02

Galaxy Theater & Discovery Hall
  • March 27 (Fri), 10:30-11:15
  • Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
  • 10:30-11:15 The Past, Present and Future of Hematopoietic Stem Cell Gene Therapies Cynthia E. Dunbar (National Institutes of Health, USA)

[SY06] Satellite Symposium 06

GlaxoSmithKline

Galaxy Theater
  • March 27 (Fri), 12:15-13:05
  • Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
  • 12:15-13:05 Triple Targeting in Myelofibrosis with Momelotinib: Integrated Therapeutic Approach via JAK1/2 and ACVR1 Inhibition Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea)

[SY07] Satellite Symposium 07

DKSH KOREA

Discovery Hall
  • March 27 (Fri), 12:15-13:05
  • Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
  • 12:15-13:05 Clinical Evidence of Romiplostim in Aplastic Anemia: Korean Expert Recommendations Silvia Park (College of Medicine, The Catholic University of Korea, Korea)

[SY08] Satellite Symposium 08

Johnson & Johnson Innovative Medicine

Universe Arena
  • March 27 (Fri), 12:15-13:05
  • Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
  • 12:15-13:05 Daratumumab in the Emerging Landscape of Functional High-Risk Multiple Myeloma Andrew Spencer (Alfred Hospital, Australia)

[SY09] Satellite Symposium 09

Gilead Sciences, Inc.

Supernova Stage
  • March 27 (Fri), 12:15-13:05
  • Deok Hwan Yang (Chonnam National University Medical School, Korea)
  • 12:15-13:05 Early CAR-T Intervention in DLBCL: Clinical Advances and Real-World Effectiveness of Axi-cel Mark Dowling (Peter MacCallum Cancer Centre, Australia)

[SY10] Satellite Symposium 10

BMS Pharmaceutical Korea

Grand 4+5
  • March 27 (Fri), 12:15-13:05
  • Dong-Wook Kim (Eulji University School of Medicine, Korea)
  • 12:15-13:05 How to Optimize CML Treatment in 2026: ELN 2025 and Molecular Guidance Elias Jabbour (MD Anderson Cancer Center, USA)

[OP05] Oral Presentation 05

Acute Leukemia 2

Galaxy Theater
  • March 27 (Fri), 13:35-14:50
  • Yong Park (Korea University College of Medicine, Korea)
    Hee Young Ju (Sungkyunkwan University School of Medicine, Korea)
  • 13:35-13:47 Development of Preclinical Leukemic Models for Acquired Resistance to a FLT3 Inhibitor Eun-Ji Choi (Asan Medical Center, University of Ulsan College of Medicine, Korea) 13:47-13:59 The Effect of Allogeneic HSCT on Pediatric nonDown Syndrome AMKL: Results from a Multicenter CALD-AMKL-18 Trial Shengqin Cheng (Children's Hospital of Soochow University, China) 13:59-14:11 Clinical Characteristics and Prognostic Implications according to Partner Genes in Adult Acute Myeloid Leukemia with KMT2A Rearrangement So Yeon Park (Seoul St. Mary's Hospital, Korea) 14:11-14:23 Combinatorial Cell-Surface Markers Derived from Single-Cell Transcriptomics Enable Precise Discrimination of LSCs from HSCs in Acute Myeloid Leukemia Smeeta Gajendra (All India Institute of Medical Sciences, India) 14:23-14:35 Refining Genomic Risk Stratification in Adult Patients with Ph-Negative All by Functional Classification of IKZF1 Deletions Seung-Hwan Lee (Seoul St. Mary’s Hospital, Korea) 14:35-14:47 Immunotargeted Therapy Challenges the Role of Second Transplantation after Post-Transplant Relapse in Adult Patients with B-ALL : A Contemporary Real-World Analysis Jaehyun Ahn (Seoul St. Mary’s Hospital, Korea)

[OP06] Oral Presentation 06

Hematopoietic Stem Cell Transplantation / Cellular Therapy

Discovery Hall
  • March 27 (Fri), 13:35-14:50
  • Byung Su Kim (College of Medicine, The Catholic University of Korea, Korea)
    Kyung Taek Hong (Seoul National University College of Medicine, Korea)
  • 13:35-13:47 Clinical Benefits of Ruxolitinib in Moderate-to-Severe CRS: Reduced Severe ICANS and Steroid Use with Preserved Survival after Pediatric CAR-T Therapy Qi Ji (Children’s Hospital of Soochow University, Jiangsu Province, China) 13:47-13:59 CD19 CAR-T Therapy for Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL): The First Investigator-Initiated Trial with Point-of-Care CAR-T Manufacturing in Korea Hyoung Jin Kang (Seoul National University College of Medicine, Korea) 13:59-14:11 Post-Autologous Stem Cell Transplantation Cytokine-Induced Killer Cell Infusion as a Post-Remission Strategy in High-Risk Lymphoma Gi June Min (Seoul St. Mary’s Hospital, Korea) 14:11-14:23 Reduced-Intensity Conditioning Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Severe Aplastic Anemia: A Single-Center Study Hyun Jin Park (Seoul National University College of Medicine, Korea) 14:23-14:35 Vedolizumab for Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Real-World VAST Study Yi Xia (Peking University People’s Hospital, China) 14:35-14:47 Distinct Dynamics of Regulatory T Cells after Allogeneic Hematopoietic Cell Transplantation Using Post-transplantation Cyclophosphamide vs. Antithymocyte Globulin Eun-Ji Choi (Asan Medical Center, University of Ulsan College of Medicine, Korea)

[OP07] Oral Presentation 07

Multiple Myeloma

Universe Arena
  • March 27 (Fri), 13:35-14:50
  • Min Kyoung Kim (Yeungnam University College of Medicine, Korea)
    Jun Ho Yi (Sungkyunkwan University School of Medicine, Korea)
  • 13:35-13:47 Prevalence and Prognostic Impact of 1p32 Deletion in Newly Diagnosed Multiple Myeloma Sreejesh Sreedharanunni (Postgraduate Institute of Medical Education and Research, India) 13:47-13:59 Single Cell Transcriptomic Profiling of Bone Marrow Reveals Progressive T Cell Exhaustion and Myeloid Activation in Multiple Myeloma and Plasma Cell Leukemia Ho Cheol Jang (Chonnam National University Hwasun Hospital, Korea) 13:59-14:11 Deep Hematologic Response Overrides the Impact of Treatment Modality on Progression-Free Survival in AL Amyloidosis: A Korean Multicenter Study Joon Young Hur (Asan Medical Center, Korea) 14:11-14:23 Mezigdomide Enhances BCMAxCD3 T-cell Engager-Induced Cytotoxicity Under High Target Cell Load Conditions Hyunsoo Cho (Seoul National University College of Medicine, Korea) 14:23-14:35 Prospective, Multicenter Phase II Study to Evaluate Clinical Benefit of Reduced-Dose Lenalidomide and Dexamethasone Based on Frailty Stratification in Elderly Unfit Patients with Newly Diagnosed Multiple Myeloma Sung-Hoon Jung (Chonnam National University Medical School, Korea) 14:35-14:47 Decoding the Role of TANGO1 in Myeloma Proteostasis and Therapeutic Vulnerability Ji Eun Lee (Yonsei University College of Medicine, Seoul National University, Korea)

[OP08] Oral Presentation 08

Cytopenia & Bone Marrow Failure

Supernova Stage
  • March 27 (Fri), 13:35-14:50
  • Young Kyung Lee (Hallym University College of Medicine, Korea)
    Yeon Jung Lim (Chungnam National University College of Medicine, Korea)
  • 13:35-13:47 Diagnostic Errors of Beta-Thalassemia by Hemoglobin Variants with Elevated Hb A2 Levels and Co-Migration with Hb F Kritsada Singha (Khon Kaen University, Mahasarakham University, Thailand) 13:47-13:59 Expanding Genetic Landscape of Inherited Bone Marrow Failure Syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023) Ye Jee Shim (Kyungpook National University Children's Hospital, Korea) 13:59-14:11 Integrative Transcriptomic Profiling Reveals Shared mRNA and lncRNA Signatures in Pediatric Bone Marrow Failure Syndromes Jong-Mi Lee (Seoul St. Mary’s Hospital, Korea) 14:11-14:23 Umbilical Cord Blood Transplantation for Primary Immunodeficiency in Children: A Ten-Year Single-Center Clinical Analysis Qingwei Wang (Children's Hospital of Soochow University, Jiangsu Provincial Center for Pediatric Hematology and Oncology, China) 14:23-14:35 First-Line Hetrombopag Combined with Immunosuppressive Therapy for Pediatric Severe Aplastic Anemia: A Prospective Randomized Controlled Trial Lingling Fu (Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, China) 14:35-14:47 Emergency Myelopoiesis and Monocyte Reprogramming Underlie Immune Dysregulation in Lymphoma-Associated Secondary Hemophagocytic Lymphohistiocytosis Jeong-Eun Kwak (Seoul National University Hospital, Korea)

[JS04] Joint Session 04 (EHA-KSH)

From Operations to Evidence: CAR T-cell Therapy Through Registry and CNS Lymphoma Practice

Galaxy Theater
  • March 27 (Fri), 15:05-16:20
  • Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
    Andrés J. M. Ferreri (University Vita-Salute San Raffaele, Italy)
  • 15:05-15:20 Operational Wisdom in CAR T Jürgen Kuball (University Medical Center Utrecht, The Netherlands) 15:20-15:35 Korean CAR T-cell Registry: Inauguration and the Current Status of CAR T-cell Therapy in Korea Ji Hyun Lee (Dong-A University College of Medicine, Korea) 15:35-15:50 CAR T-cell Therapy for Primary and Secondary CNS Lymphomas Andrés J. M. Ferreri (University Vita-Salute San Raffaele, Italy) 15:50-16:05 CAR T-cell Therapy in Primary and Secondary CNS Lymphomas in Korea Hyungwoo Cho (Asan Medical Center, University of Ulsan College of Medicine, Korea) 16:05-16:20 Discussion

[SS10] Scientific Session 10

Pediatric Malignancies: From Patients to Survivors

Discovery Hall
  • March 27 (Fri), 15:05-16:20
  • Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
    Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
  • 15:05-15:30 Genomics and Transplant Strategies in Pediatric Myeloid Malignancies Jae Wook Lee (College of Medicine, The Catholic University of Korea, Korea) 15:30-15:55 Virus-Specific and Next-Generation T-cell Therapy in Pediatric Hematologic Malignancy Catherine M. Bollard (Children’s National Hospital and The George Washington University, USA) 15:55-16:20 Cancer Survivorship after the Cure of Childhood Blood Cancers: Risk Based Surveillance Sharon M. Castellino (Emory University School of Medicine, USA)

[SS11] Scientific Session 11

Transforming the Therapeutic Landscape of AML: From Biology to Targeted Therapies

Universe Arena
  • March 27 (Fri), 15:05-16:20
  • Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
    Il-Hoan Oh (College of Medicine, The Catholic University of Korea, Korea)
  • 15:05-15:30 Stem Cells in Human AML Ravindra Majeti (Stanford University, USA) 15:30-15:55 Evolving Frontiers in Targeted Therapy: Menin Inhibition in AML Eytan M. Stein (Memorial Sloan Kettering Cancer Center, USA) 15:55-16:20 HMA + Venetoclax + Targeted Agents: Clinical Evidence and Future of Triplet Therapy in AML Tapan Kadia (The University of Texas MD Anderson Cancer Center, USA)

[ES05] Education Session 05

Big Data and AI in Hematology Research

Supernova Stage
  • March 27 (Fri), 15:05-16:20
  • Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
    Dae Sik Kim (Korea University College of Medicine, Korea)
  • 15:05-15:30 Real-World Effectiveness of Immunotherapy in Hematologic Malignancies: Evidence from Big Data Sung-Soo Park (College of Medicine, The Catholic University of Korea, Korea) 15:30-15:55 Digital Healthcare Innovation: Real-World Applications of Big Data and AI Yoon Sup Choi (Digital Healthcare Partners (DHP), Korea) 15:55-16:20 Wise Hematology Life: Practical Integration of Large Language Models and Agentic AI into Clinical Research Jeong-Moo Lee (Ewha Womans University College of Medicine, Korea)

[SS12] Scientific Session 12

Expanding Therapeutic Horizons in ITP and TTP

Discovery Hall
  • March 27 (Fri), 16:35-17:50
  • Dae Chul Jeong (College of Medicine, The Catholic University of Korea, Korea)
    Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea)
  • 16:35-17:00 Real World Long Term TPO-RA: Sustaining Remission or Time to Stop? Nichola Cooper (Imperial College Health Care NHS Trust, UK) 17:00-17:25 A New Chapter in ITP Management - Updated Trials Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea) 17:25-17:50 Caplacizumab and the Changing Landscape of TTP Management Shruti Chaturvedi (Johns Hopkins University School of Medicine, USA)

[SS13] Scientific Session 13

Other Plasma Cell Disorders: From Diagnosis to Mechanistic Insights

Universe Arena
  • March 27 (Fri), 16:35-17:50
  • Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
    Ho Sup Lee (Kosin University College of Medicine, Korea)
  • 16:35-17:00 AL Amyloidosis: A Comprehensive Update from Fundamentals to Emerging Therapies Efstathios Kastritis (National and Kapodistrian University of Athens, Greece) 17:00-17:25 Monoclonal Gammopathy and the Kidney: A Comprehensive Approach to MGRS Nelson Leung (Mayo Clinic, USA) 17:25-17:50 Novel Biological and Clinical Insights into POEMS Syndrome: Pathophysiology and Real-World Treatment Outcomes from Japan Emiko Sakaida (Chiba University Hospital, Japan)

[ES06] Education Session 06

Toxicity Masterclass: Managing CRS, Cytopenia, and Infections in T Cell Engaging Therapies

Supernova Stage
  • March 27 (Fri), 16:35-17:50
  • Ki-Seong Eom (College of Medicine, The Catholic University of Korea, Korea)
    Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
  • 16:35-17:00 CRS and ICANS: Early Detection and Personalized Management Jinchul Kim (Inha University College of Medicine, Korea) 17:00-17:25 Prolonged Cytopenia after TCEs: Mechanisms, Biomarkers, and Risk Stratification Sang Eun Yoon (Sungkyunkwan University School of Medicine, Korea) 17:25-17:50 Preventing Infections in TCEs: Risk Stratification and Prophylaxis Ja Min Byun (Seoul National University College of Medicine, Korea)

Go top

Go top

Hosted by
Supported by